Navigation Links
Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
Date:2/18/2009

any's preliminary studies and preclinical research; competition and the timing of projects and trends in future operating performance, the Company's ability to meet its funding milestones under its financing transaction, the Company's ability to comply with the continued listing standards of the AMEX, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

    Company Contact:                            Investor Relations Contact:
    Senesco Technologies, Inc.                  FD
    Joel Brooks                                 Brian Ritchie
    Chief Financial Officer                     brian.ritchie@fd.com
    jbrooks@senesco.com                         212-850-5600
     

                      SENESCO TECHNOLOGIES, INC. AND SUBSIDIARY
                            (A DEVELOPMENT STAGE COMPANY)
                   CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                     (unaudited)

                                    For the Three   For the Three
                                     Months Ended    Months Ended
                                     December 31,    December 31,
                                         2008            2007

    Revenue                                 $--         $6,250

    Operating Expenses:

      General and administrative        649,056        585,851
      Research and development          579,286        392
'/>"/>
SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
2. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
3. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
5. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
6. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
7. Senesco Technologies to Present at BIO 2008 Business Forum
8. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
9. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
10. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
11. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... announced that the 30-day review period following the ... for ocular indications with the U.S. Food and ... is now active. Logo -  ...
(Date:8/31/2015)... Israel , Aug. 31, 2015 ... Dario™ Diabetes Management Solution, today announced it recently ... million. Funds will be used to support the ... the Dario, a mobile, cloud-based, diabetes management solution ... stylish, ,all-in-one, pocket-sized, blood glucose monitoring device, and ...
(Date:8/31/2015)... ... ... There’s a new treatment option for excessive menstrual bleeding – The Minerva ... system in the last 14 years, and the only endometrial ablation product to combine ... 66%, the high Patient Satisfaction rate of 98%, and the fastest procedure time (3 ...
(Date:8/28/2015)... August 28, 2015 According to ... Sera, Cryogenic Storage Systems, Thawing Equipment, Alarms), by Biospecimen ... Clinical Trials), End User - Global Forecast to 2020", ... to reach USD 3,731.03 Million by 2020 from USD ... 11.65% between 2015 and 2020. Browse ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5
... GenVault Corporation, the,leader in room temperature biosample ... will be presenting data showing stabilization,of RNA on ... room,temperature at the 18th International Symposium on Human ... storage media is a novel technology utilizing ceramic,nanoparticles ...
... Abiant, Inc., an Illinois based company,specializing ... and disease diagnosis, announces the successful closing ... Angels, an angel,network specializing in early-stage technology, ... other participants. Abiant has developed,partnerships with large ...
... Inc. (Nasdaq:,PPDI) will release its third quarter 2007 financial ... earnings release will be available,on the PPD Web site ... On Wednesday, October 24, at 9 a.m. ET, PPD ... discuss financial results and the,overall business environment. A Q&A ...
Cached Biology Technology:GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 2Abiant, Inc. Announces Close on Investment Round 2PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call 2
(Date:8/31/2015)... 31, 2015 Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ... Arabia Biomedical Sensors Market - Growth, Trends & Forecasts ... The Saudi Arabia Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:8/24/2015)... 24, 2015  Based on its recent analysis of the ... 2015 African Biometrics Company of the Year Award. DERMALOG is ... success in Africa . It has particularly ... has implemented one of the largest biometric mass applications in ... the Central Bank of Nigeria with ...
(Date:8/18/2015)... N.J. , Aug. 18, 2015 /PRNewswire/ ... a key contributor to the Submission Content ... by IRISS, a non-profit forum. Dedicated to the ... provides a neutral platform for industry, vendors, ... share information and work towards a standard ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... Mayo Clinic have discovered the first gender-linked susceptibility gene ... 11 online edition of Nature Genetics , they ... of patients with Alzheimer,s disease. The research showed that ... the PCDH11X gene, found on the X chromosome, are ...
... BOSS-UROCKVILLE, Md., Jan. 8 The U.S. Department of Defense ... LMT ) an industry leader capable of being awarded ... Unrestricted (BOSS-U) vehicle. As part of the award process, ... indefinite delivery, indefinite quantity (ID/IQ) program. , ...
... Now, a pair of Scripps Research Institute scientists has taken ... synthesized for the first time RNA enzymes that can replicate ... components, and the process proceeds indefinitely. The work ... Express , the advanced, online edition of the journal ...
Cached Biology News:Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimer's 2Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimer's 3Lockheed Martin Team Wins Role on Key Department of Defense Biometrics Contract Vehicle 2Scripps scientists develop first examples of RNA that replicates itself indefinitely 2Scripps scientists develop first examples of RNA that replicates itself indefinitely 3Scripps scientists develop first examples of RNA that replicates itself indefinitely 4
... Cell Lines stably express the regulatory ... line is functionally tested for induction ... expression control vector pGene/V5-His/lacZ and by ... with mifepristone (Figure 1). These cell ...
... for 15-20 enhancements when used as directed, ... System is designed to amplify the desired signal detected ... evaluating proteins with low expression., Membrane ... blocking the membrane; 1x solution; 250 ml, ...
... Prior to siRNA library screening, ... be identified and verified for ... Silencer CellReady siRNA Transfection Optimization ... for optimizing transfection conditions in ...
... The MX80 Series of positioning slides ... motor, ballscrew, leadscrew, micrometer, and manual. ... high performance, cost-effective multi-axis systems. These ... bearings, encoder resolutions down to 10 ...
Biology Products: